 EDEN PRAIRIE, Minn., Sept. 26, 2022 GLOBE NEWSWIRE -- Miromatrix Medical Inc. NASDAQ: MIRO, a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients lives, today announced CEO Jeff Ross will present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event. The two-day virtual event held this year on September 28-29, will focus the first day on solid organ transplant SOT, in particular, kidney transplants, and the second day on the unmet need and innovations in hematopoietic stem cell transplant HSCT. 